封面
市场调查报告书
商品编码
1604694

人工胰臟设备系统市场:按设备类型、治疗类型和最终用户划分 - 全球预测 2025-2030

Artificial Pancreas Device System Market by Device Type (Control-to-Range System, Control-to-Target System, Threshold Suspended Device System), Treatment Type (Bi-Hormonal, Hybrid, Insulin Only), End-User - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年,人工胰臟装置系统市值为2.4822亿美元,预计到2024年将达到2.9766亿美元,复合年增长率为20.01%,到2030年将达到8.8996亿美元。

人工胰臟装置系统 (APDS) 包括自动注射胰岛素的闭合迴路系统,旨在模仿健康胰臟的葡萄糖调节功能。对此类系统的需求源于糖尿病盛行率的增加以及改善血糖控制以提高糖尿病患者的生活品质并降低併发症风险的需要。 APDS 主要应用于第 1 型和第 2 型糖尿病的管理,最终用途包括医院、居家医疗和诊所。该市场是由血糖监测技术的进步、医疗保健意识的提高和支持性监管政策等因素所推动的。此外,穿戴式健康技术的日益普及以及与智慧型手机应用程式的整合将增强用户参与和监控,进一步扩大市场范围。儘管有这些积极因素,市场成长仍面临高成本、严格监管要求和限制性报销政策等挑战,这使得广泛采用变得复杂化。设备精度和安全性等技术挑战也是潜在的限制。然而,存在着透过降低成本和策略联盟来增加准入的机会。专注于提高仪器精度、小型化和增强资料分析的研发投资提供了重大机会。探索机器学习和人工智慧进行预测分析和个人化治疗计画是技术创新的一条有前途的途径。市场开拓参与者应考虑将其重点扩展到已开发地区之外,以占领新兴市场,因为糖尿病盛行率的上升和医疗保健投资的增加为成长提供了肥沃的土壤。该行业仍然充满活力,其特点是技术快速进步和监管演变。能够在拥抱技术和协作的同时克服这些挑战的公司将获得显着的收益。总体而言,关注民主化和改进设备介面对于人工胰臟设备市场的持续成长至关重要。

主要市场统计
基准年[2023] 2.4822亿美元
预测年份 [2024] 2.9766亿美元
预测年份 [2030] 88996万美元
复合年增长率(%) 20.01%

市场动态:快速发展的人工胰臟设备系统市场的关键市场洞察

人工胰臟装置系统市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 由于生活方式的改变和人口老化,糖尿病盛行率上升
    • 增加可支配收入并提高对管理糖尿病选择的认识
    • 胰臟癌的盛行率和对血糖控制自动化系统的需求
  • 市场限制因素
    • 人工胰臟系统高成本
  • 市场机会
    • 加大该领域研发投入
    • 政府和组织提供资金以提高治疗质量
  • 市场挑战
    • 无法治疗肌肉骨骼糖尿病的系统

波特五力:引领人工胰臟设备系统市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势,解决弱点并避免潜在的挑战,从而确保更强大的市场地位。

PESTLE分析:了解人工胰臟设备系统市场的外部影响

外部宏观环境因素在塑造人工胰腺设备系统市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并帮助他们做出积极主动的决策。

市场占有率分析 了解人工胰臟装置系统市场的竞争状况

人工胰臟设备系统市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的洞察力,使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵人工胰臟设备系统市场供应商的绩效评估

FPNV定位矩阵是评估人工胰臟装置系统市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商,从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商,并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议,以规划人工胰腺设备系统市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说,对人工胰臟设备系统市场的策略分析至关重要。透过审查关键资源、能力和绩效指标,公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战,利用新的商机,并取得长期成功。

本报告对市场进行了全面分析,涵盖关键重点领域:

1. 市场渗透率:详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。

3. 市场多元化:分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报:彻底分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新:重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题,以帮助相关人员做出明智的决策:

1.目前的市场规模和未来的成长预测是多少?

2. 哪些产品、区隔市场和地区提供最佳投资机会?

3.塑造市场的主要技术趋势和监管影响是什么?

4.主要厂商的市场占有率和竞争地位如何?

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 由于生活方式的改变和人口老化,糖尿病发生率增加
      • 增加可支配所得和对糖尿病管理方案的认识
      • 胰臟癌的盛行率和对血糖控制自动化系统的需求
    • 抑制因素
      • 人工胰臟装置系统高成本
    • 机会
      • 加大该领域研发投入
      • 政府和组织提供资金以提高护理质量
    • 任务
      • 该系统无法治疗运动糖尿病
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依设备类型分類的人工胰臟设备系统市场

  • 控制距离系统
  • 控制目标系统
  • 阈值吊挂装置系统

第七章依治疗类型分類的人工胰臟装置系统市场

  • 双激素
  • 混合
  • 仅胰岛素

第八章人工胰臟设备系统市场:依最终用户分类

  • 医院
  • 调查机构

第九章北美及南美人工胰臟设备系统市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太人工胰臟设备系统市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲人工胰臟装置系统市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Admetsys
  • Beta Bionics, Inc.
  • Bigfoot Biomedical, Inc.
  • Defymed
  • Dexcom, Inc.
  • Diabeloop SA
  • DreaMed Diabetes Ltd.
  • EOFlow Co., Ltd.
  • Glooko, Inc.
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • PharmaCyte Biotech, Inc.
  • Tandem Diabetes Care, Inc.
  • Vertex Pharmaceuticals Incorporated
Product Code: MRR-4369010658A1

The Artificial Pancreas Device System Market was valued at USD 248.22 million in 2023, expected to reach USD 297.66 million in 2024, and is projected to grow at a CAGR of 20.01%, to USD 889.96 million by 2030.

The artificial pancreas device system (APDS) encompasses closed-loop systems that automate insulin delivery, aiming to mimic the glucose-regulating function of a healthy pancreas. The necessity for such systems arises from the growing prevalence of diabetes and the need for improved glycemic control, which can enhance quality of life and reduce the risk of complications for diabetic patients. APDS is primarily applied in managing both Type 1 and Type 2 diabetes, with end-use spanning hospitals, home care, and clinics. The market is driven by factors such as advancements in glucose monitoring technologies, increasing healthcare awareness, and supportive regulatory policies. Additionally, the growing adoption of wearable health technology and integration with smartphone applications enhances user engagement and monitoring, further expanding the market's scope. Despite these positives, market growth faces challenges such as high costs, stringent regulatory requirements, and limited reimbursement policies, which complicate broad-scale adoption. Technical challenges, including device accuracy and security, also pose potential limitations. However, opportunities exist in expanding access through cost reduction and strategic partnerships. Investment in R&D focused on improving device accuracy, miniaturization, and enhanced data analytics provides significant opportunities. Exploration of machine learning and AI for predictive analytics and personalized treatment plans are promising avenues for innovation. Market players should consider expanding their focus beyond developed regions to capture emerging markets, where an increasing prevalence of diabetes and rising healthcare investment present a fertile ground for growth. The industry remains dynamic, characterized by rapid technological advances and evolving regulations. Companies that can navigate these challenges while embracing technology and collaboration stand to make significant gains. Overall, a focus on democratizing access and improving device interfaces is essential for sustained growth in the artificial pancreas device market.

KEY MARKET STATISTICS
Base Year [2023] USD 248.22 million
Estimated Year [2024] USD 297.66 million
Forecast Year [2030] USD 889.96 million
CAGR (%) 20.01%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Pancreas Device System Market

The Artificial Pancreas Device System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of diabetes due to changing lifestyle and elderly population
    • Increase in disposable income and awareness on options to manage diabetes
    • Prevalence of pancreatic cancer and demand for automated systems for glycemic control
  • Market Restraints
    • High cost of artificial pancreas device systems
  • Market Opportunities
    • Growing investments in research and development in the field
    • Availability of funds from the governments and organizations to improve the quality of treatment
  • Market Challenges
    • Inability of the system to treat athletic diabetes

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Pancreas Device System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Pancreas Device System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Pancreas Device System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Pancreas Device System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Pancreas Device System Market

A detailed market share analysis in the Artificial Pancreas Device System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Pancreas Device System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Pancreas Device System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Pancreas Device System Market

A strategic analysis of the Artificial Pancreas Device System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Pancreas Device System Market, highlighting leading vendors and their innovative profiles. These include Admetsys, Beta Bionics, Inc., Bigfoot Biomedical, Inc., Defymed, Dexcom, Inc., Diabeloop SA, DreaMed Diabetes Ltd., EOFlow Co., Ltd., Glooko, Inc., Insulet Corporation, Johnson & Johnson Services, Inc., Medtronic PLC, PharmaCyte Biotech, Inc., Tandem Diabetes Care, Inc., and Vertex Pharmaceuticals Incorporated.

Market Segmentation & Coverage

This research report categorizes the Artificial Pancreas Device System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device Type, market is studied across Control-to-Range System, Control-to-Target System, and Threshold Suspended Device System.
  • Based on Treatment Type, market is studied across Bi-Hormonal, Hybrid, and Insulin Only.
  • Based on End-User, market is studied across Hospitals and Research Institute.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of diabetes due to changing lifestyle and elderly population
      • 5.1.1.2. Increase in disposable income and awareness on options to manage diabetes
      • 5.1.1.3. Prevalence of pancreatic cancer and demand for automated systems for glycemic control
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of artificial pancreas device systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing investments in research and development in the field
      • 5.1.3.2. Availability of funds from the governments and organizations to improve the quality of treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Inability of the system to treat athletic diabetes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Pancreas Device System Market, by Device Type

  • 6.1. Introduction
  • 6.2. Control-to-Range System
  • 6.3. Control-to-Target System
  • 6.4. Threshold Suspended Device System

7. Artificial Pancreas Device System Market, by Treatment Type

  • 7.1. Introduction
  • 7.2. Bi-Hormonal
  • 7.3. Hybrid
  • 7.4. Insulin Only

8. Artificial Pancreas Device System Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Research Institute

9. Americas Artificial Pancreas Device System Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Artificial Pancreas Device System Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Artificial Pancreas Device System Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Admetsys
  • 2. Beta Bionics, Inc.
  • 3. Bigfoot Biomedical, Inc.
  • 4. Defymed
  • 5. Dexcom, Inc.
  • 6. Diabeloop SA
  • 7. DreaMed Diabetes Ltd.
  • 8. EOFlow Co., Ltd.
  • 9. Glooko, Inc.
  • 10. Insulet Corporation
  • 11. Johnson & Johnson Services, Inc.
  • 12. Medtronic PLC
  • 13. PharmaCyte Biotech, Inc.
  • 14. Tandem Diabetes Care, Inc.
  • 15. Vertex Pharmaceuticals Incorporated

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET DYNAMICS
  • TABLE 7. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL-TO-RANGE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL-TO-TARGET SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY THRESHOLD SUSPENDED DEVICE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY BI-HORMONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HYBRID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN ONLY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023